Cholesterol homeostasis: a key to prevent or slow down neurodegeneration
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Neurodegeneration, a common feature for many brain disorders, has severe consequences on the mental and physical health of an individual. Typically human neurodegenerative diseases are devastating illnesses that predominantly affect elderly people, progress slowly, and lead to disability and premature death; however they may occur at all ages. Despite extensive research and investments, current therapeutic interventions against these disorders treat solely the symptoms. Therefore, since the underlying mechanisms of damage to neurons are similar, in spite of etiology and background heterogeneous, it will be of interest to identify possible trigger point of neurodegeneration enabling development of drugs and/or prevention strategies that target many disorders simultaneously. Among the factors that have been identified so far to cause neurodegeneration, failures in cholesterol homeostasis are indubitably the best investigated. The aim of this review is to critically discuss some of the main results reported in the recent years in this field mainly focusing on the mechanisms that, by recovering perturbations of cholesterol homeostasis in neuronal cells, may correct clinically relevant features occurring in different neurodegenerative disorders and, in this regard, also debate the current potential therapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766
Identification and Evaluation of Children With Autism Spectrum Disorders
Johnson, C. P., Myers, S. M., & and the Council on Children With Disabilities (2007) · Pediatrics · doi:10.1542/peds.2007-2361 · Cited by 2,011
Dietschy, J. M., & Turley, S. D. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400004-jlr200 · Cited by 1,095 · cited 5×
“The specificity of lipids, mainly FC and their patterns of accumulation during development (Dietschy and Turley, 2004; Dietschy, 2009), contributes to the direct and permissive roles that these compounds play in signal transduction as well as in both activation and deactivation of raft resident…”
BackgroundInfluentialSpilman, P., Podlutskaya, N., Hart, M. J., Debnath, J., Gorostiza, O., Bredesen, D., Richardson, A., Strong, R., & Galvan, V. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009979 · Cited by 1,033
Functional brain development in humans
Johnson, M. H. (2001) · Nature Reviews Neuroscience · doi:10.1038/35081509 · Cited by 980 · cited 4×
“These regions are enriched in unesterified (free) cholesterol (FC) and other specific lipid compounds (sphingolipids, plasmenylethanolamine, anionic phospholipids, plasmalogens, and arachidonic acid containing phospholipids) (Simons and Ehehalt, 2002; Korade and Kenworthy, 2008).”
BackgroundInfluentialAge-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease
Bartzokis, G. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.03.001 · Cited by 968 · cited 8×
“INTRODUCTION: NEURODEGENERATION AND CHOLESTEROL Progressive loss of structure or function of neurons, neurodegeneration, (Bartzokis, 2004) is a common feature for many neurodegenerative diseases such as Alzheimer’s disease (AD) (Pani et al.”
BackgroundInfluentialReversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis
Ehninger, D., Han, S., Shilyansky, C., Zhou, Y., Li, W., Kwiatkowski, D. J., Ramesh, V., & Silva, A. J. (2008) · Nature Medicine · doi:10.1038/nm1788 · Cited by 882
Maturation of white matter in the human brain: A review of magnetic resonance studies.
Paus, T., Collins, D. L., Evans, A. C., Leonard, G., Pike, B., & Zijdenbos, A. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00434-2 · Cited by 863
High cholesterol level is essential for myelin membrane growth
Saher, G., Brügger, B., Lappe-Siefke, C., Möbius, W., Tozawa, R.-I., Wehr, M. C., Wieland, F., Ishibashi, S., & Nave, K.-A. (2005) · Nature Neuroscience · doi:10.1038/nn1426 · Cited by 799 · cited 1×
“…had severely disturbed myelin in their brains, and exhibited ataxia (un-coordinated muscle movements) and tremor indicating that cholesterol is an indispensable component of myelin membranes that contribute proper production of the myelin sheath and their function in synapses (Saher et al., 2005).”
BackgroundNeurosteroids: biochemistry and clinical significance
Mellon, S. H., & Griffin, L. D. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00503-3 · Cited by 538
Central nervous system: cholesterol turnover, brain development and neurodegeneration
Dietschy, J. M. (2009) · bchm · doi:10.1515/bc.2009.035 · Cited by 394
WILENS, T. E., BIEDERMAN, J., BROWN, S., TANGUAY, S., MONUTEAUX, M. C., BLAKE, C., & SPENCER, T. J. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200203000-00005 · Cited by 391 · cited 1×
“…most common psychiatric disorder in children, affecting about 3–5% of children globally (Spencer et al., 1999) and is characterized primarily by the co-existence of attention problems and hyperactivity, with symptoms starting before seven years of age (Waschbusch et al., 2002; Wilens et al., 2002).”
BackgroundLipid rafts, cholesterol, and the brain
Korade, Z., & Kenworthy, A. K. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.02.019 · Cited by 342
Cholesterol: its regulation and role in central nervous system disorders
Orth, M., & Bellosta, S. (2012) · Cholesterol · doi:10.1155/2012/292598 · Cited by 339
Age-related Volumetric Changes of Brain Gray and White Matter in Healthy Infants and Children
Matsuzawa, J. (2001) · Cerebral Cortex · doi:10.1093/cercor/11.4.335 · Cited by 315
A systems approach to prion disease
Hwang, D., Lee, I. Y., Yoo, H., Gehlenborg, N., Cho, J., Petritis, B., Baxter, D., Pitstick, R., Young, R., Spicer, D., et al. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.10 · Cited by 287
Impact of Comorbid Oppositional or Conduct Problems on Attention-Deficit Hyperactivity Disorder
KUHNE, M., SCHACHAR, R., & TANNOCK, R. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199712000-00020 · Cited by 209 · cited 2×
“…is the most common psychiatric disorder in children, affecting about 3–5% of children globally (Spencer et al., 1999) and is characterized primarily by the co-existence of attention problems and hyperactivity, with symptoms starting before seven years of age (Waschbusch et al., 2002; Wilens et…”
BackgroundBryleva, E. Y., Rogers, M. A., Chang, C. C. Y., Buen, F., Harris, B. T., Rousselet, E., Seidah, N. G., Oddo, S., LaFerla, F. M., Spencer, T. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913828107 · Cited by 209
Apolipoprotein E and cholesterol in aging and disease in the brain
de Chaves, E. P., Narayanaswami, V., Christoffersen, C., & Nielsen, L. B. (2008) · Future Lipidology · doi:10.2217/17460875.3.5.505 · Cited by 164
Brain cholesterol in normal and pathological aging
Martin, M., Dotti, C. G., & Ledesma, M. D. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.03.011 · Cited by 162 · cited 2×
“However, recent results indicate that both cholesterol synthesis and degradation are active in the adult brain as well and that alterations in these mechanisms profoundly influence higher-order brain functions (Martin et al., 2010; Orth and Bellosta, 2012).”
BackgroundReactive aggression in boys with disruptive behavior disorders: behavior, physiology, and affect
Waschbusch, D. A., Pelham, W. E., Jennings, J. R., Greiner, A. R., Tarter, R. E., & Moss, H. B. (2002) · Journal of Abnormal Child Psychology · doi:10.1023/a:1020867831811 · Cited by 146
Elevated stearoyl-CoA desaturase in brains of patients with Alzheimer’s disease
Astarita, G., Jung, K.-M., Vasilevko, V., DiPatrizio, N. V., Martin, S. K., Cribbs, D. H., Head, E., Cotman, C. W., & Piomelli, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024777 · Cited by 146
Ultrastructural Localization of Intraneuronal Aβ-Peptide in Alzheimer Disease Brains
Gómez-Ramos, P., & Asunción Morán, M. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-11109 · Cited by 76
Hypothesis: The Role of Sterols in Autism Spectrum Disorder
Lee, R. W. Y., & Tierney, E. (2011) · Autism Research and Treatment · doi:10.1155/2011/653570 · Cited by 30 · cited 5×
“Nowadays, more and more researchers talk about ASD as neurodegenerative disorders (Hagerman, 2006).”
BackgroundInfluential
Cited by
Ras Conformational Ensembles, Allostery, and Signaling
Lu, S., Jang, H., Muratcioglu, S., Gursoy, A., Keskin, O., Nussinov, R., & Zhang, J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00542 · Cited by 355
Microdomains, Inflammation, and Atherosclerosis
Sorci-Thomas, M. G., & Thomas, M. J. (2016) · Circulation Research · doi:10.1161/circresaha.115.306246 · Cited by 165
Bai, X., Mai, M., Yao, K., Zhang, M., Huang, Y., Zhang, W., Guo, X., Xu, Y., Zhang, Y., Qurban, A., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01338-3 · Cited by 51
Cholesterol Dysmetabolism in Alzheimer’s Disease: A Starring Role for Astrocytes?
Staurenghi, E., Giannelli, S., Testa, G., Sottero, B., Leonarduzzi, G., & Gamba, P. (2021) · Antioxidants · doi:10.3390/antiox10121890 · Cited by 44
Henry, N., Krammer, E.-M., Stengel, F., Adams, Q., Van Liefferinge, F., Hubin, E., Chaves, R., Efremov, R., Aebersold, R., Vandenbussche, G., et al. (2018) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1006165 · Cited by 42
Metadata
- Authors
- Anchisi, L., Dessì, S., Pani, A., & Mandas, A.
- Venue
- Frontiers in Physiology
- Publisher
- Frontiers Media SA
- Published
- 2013
- Volume
- 3
- Pages
- 486-486
- ISSN
- 1664-042X (ISSN-L)
- OpenAlex
- W2070868291
- Cited by
- 91
- References
- 24
- FWCI
- 5.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.